Paul Tudor Jones's NAGE Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 86,059 shares of Niagen Bioscience, Inc. (NAGE) worth $274,528, representing 0.00% of the portfolio. First purchased in 2024-Q4, this short-term holding has been held for 7 quarters.
Based on 13F filings, Paul Tudor Jones has maintained this position in NAGE for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2025, adding 154,230 shares. Largest reduction occurred in Q2 2025, reducing 212,250 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Niagen Bioscience (NAGE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Niagen Bioscience (NAGE) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +86,059 | New Buy | 86,059 | $3.19 |
| Q1 2026 | -56,536 | Sold Out | 0 | $0.00 |
| Q4 2025 | +56,536 | New Buy | 56,536 | $6.36 |
| Q3 2025 | -159,548 | Sold Out | 0 | $0.00 |
| Q2 2025 | -212,250 | Reduce 57.09% | 159,548 | $14.41 |
| Q1 2025 | +154,230 | Add 70.89% | 371,798 | $6.90 |
| Q4 2024 | +217,568 | New Buy | 217,568 | $5.30 |
Paul Tudor Jones's Niagen Bioscience Investment FAQs
Paul Tudor Jones first purchased Niagen Bioscience, Inc. (NAGE) in Q4 2024, acquiring 217,568 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Niagen Bioscience, Inc. (NAGE) for 7 quarters since Q4 2024.
Paul Tudor Jones's largest addition to Niagen Bioscience, Inc. (NAGE) was in Q4 2024, adding 217,568 shares worth $1.15 M.
According to the latest 13F filing for Q2 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 86,059 shares of Niagen Bioscience, Inc. (NAGE), valued at approximately $274,528.
As of the Q2 2026 filing, Niagen Bioscience, Inc. (NAGE) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Niagen Bioscience, Inc. (NAGE) was 371,798 shares, as reported at the end of Q1 2025.